{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:42:43Z","timestamp":1792194163356,"version":"4.4.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30 DK-026743"],"award-info":[{"award-number":["P30 DK-026743"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>AKI is commonly encountered in patients with decompensated cirrhosis, and it is associated with unfavorable outcomes. Among factors specific to cirrhosis, hepatorenal syndrome type 1, also referred to as hepatorenal syndrome-AKI, is the most salient and unique etiology. Patients with cirrhosis are vulnerable to traditional causes of AKI, such as prerenal azotemia, acute tubular injury, and acute interstitial nephritis. In addition, other less common etiologies of AKI specifically related to chronic liver disease should be considered, including abdominal compartment syndrome, cardiorenal processes linked to cirrhotic cardiomyopathy and portopulmonary hypertension, and cholemic nephropathy. Furthermore, certain types of GN can cause AKI in cirrhosis, such as IgA nephropathy or viral hepatitis related. Therefore, a comprehensive diagnostic approach is needed to evaluate patients with cirrhosis presenting with AKI. Management should be tailored to the specific underlying etiology. Albumin-based volume resuscitation is recommended in prerenal AKI. Acute tubular injury and acute interstitial nephritis are managed with supportive care, withdrawal of the offending agent, and, potentially, corticosteroids in acute interstitial nephritis. Short of liver transplantation, vasoconstrictor therapy is the primary treatment for hepatorenal syndrome type 1. Timing of initiation of vasoconstrictors, the rise in mean arterial pressure, and the degree of cholestasis are among the factors that determine vasoconstrictor responsiveness. Large-volume paracentesis and diuretics are indicated to relieve intra-abdominal hypertension and renal vein congestion. Direct-acting antivirals with or without immunosuppression are used to treat hepatitis B\/C\u2013associated GN. In summary, AKI in cirrhosis requires careful consideration of multiple potentially pathogenic factors and the implementation of targeted therapeutic interventions.<\/jats:p>","DOI":"10.2215\/cjn.03040322","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T11:18:27Z","timestamp":1659007107000},"page":"1674-1684","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":71,"title":["Acute Kidney Injury in Patients with Liver Disease"],"prefix":"10.2215","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2935-0245","authenticated-orcid":false,"given":"Giuseppe","family":"Cullaro","sequence":"first","affiliation":[{"name":"Department of Medicine, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha Rani","family":"Kanduri","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ochsner Health, New Orleans, Louisiana"},{"name":"Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos Q.","family":"Velez","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Ochsner Health, New Orleans, Louisiana"},{"name":"Ochsner Clinical School, The University of Queensland, Brisbane, Queensland, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11]]},"reference":[{"key":"B1-20241015","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jhep.2020.04.043","article-title":"Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis\u2014A US population-based study","volume":"73","author":"Desai","year":"2020","journal-title":"J Hepatol"},{"key":"B2-20241015","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/lt.25694","article-title":"Chronic kidney disease in liver transplant candidates: A rising burden impacting post-liver transplant outcomes","volume":"26","author":"Cullaro","year":"2020","journal-title":"Liver Transpl"},{"key":"B3-20241015","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.cgh.2013.03.018","article-title":"Acute kidney injury in patients with cirrhosis: Perils and promise","volume":"11","author":"Belcher","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B4-20241015","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1007\/s10620-021-07159-z","article-title":"Association between kidney dysfunction types and mortality among hospitalized patients with cirrhosis","volume":"67","author":"Cullaro","year":"2022","journal-title":"Dig Dis Sci"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/j.cgh.2019.01.043","article-title":"Association between renal function pattern and mortality in patients with cirrhosis","volume":"17","author":"Cullaro","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.jhep.2019.12.020","article-title":"Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomes","volume":"72","author":"Bassegoda","year":"2020","journal-title":"J Hepatol"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/lt.25454","article-title":"Impact of chronic kidney disease on outcomes in cirrhosis","volume":"25","author":"Wong","year":"2019","journal-title":"Liver Transpl"},{"key":"B8-20241015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro","year":"1994","journal-title":"Arch Intern Med"},{"key":"B9-20241015","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/hep.26704","article-title":"Glomerular filtration rate equations for liver-kidney transplantation in patients with cirrhosis: Validation of current recommendations","volume":"59","author":"Francoz","year":"2014","journal-title":"Hepatology"},{"key":"B10-20241015","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hep.28891","article-title":"Development and validation of a mathematical equation to estimate glomerular filtration rate in cirrhosis: The royal free hospital cirrhosis glomerular filtration rate","volume":"65","author":"Kalafateli","year":"2017","journal-title":"Hepatology"},{"key":"B11-20241015","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.30321","article-title":"A model for glomerular filtration rate assessment in liver disease (GRAIL) in the presence of renal dysfunction","volume":"69","author":"Asrani","year":"2019","journal-title":"Hepatology"},{"key":"B12-20241015","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJMoa2103753","article-title":"Race, genetic ancestry, and estimating kidney function in CKD","volume":"385","author":"Hsu","year":"2021","journal-title":"N Engl J Med"},{"key":"B13-20241015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/liv.13600","article-title":"Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study","volume":"38","author":"Maiwall","year":"2018","journal-title":"Liver Int"},{"key":"B14-20241015","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1002\/lt.26216","article-title":"Estimating glomerular filtration rate in cirrhosis using creatinine-based and cystatin C-based equations: Systematic review and meta-analysis","volume":"27","author":"Singapura","year":"2021","journal-title":"Liver Transpl"},{"key":"B15-20241015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jhep.2019.07.002","article-title":"News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document","volume":"71","author":"Angeli","year":"2019","journal-title":"J Hepatol"},{"key":"B16-20241015","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/j.ackd.2015.06.009","article-title":"Acute kidney injury in liver disease: Role of biomarkers","volume":"22","author":"Belcher","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"issue":"Suppl 1","key":"B17-20241015","doi-asserted-by":"crossref","first-page":"e407","DOI":"10.1097\/MEG.0000000000002120","article-title":"The prognostic impact of different stages of acute kidney injury in patients with decompensated cirrhosis: A prospective cohort study","volume":"33","author":"Le\u00e3o","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B18-20241015","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"key":"B19-20241015","doi-asserted-by":"crossref","first-page":"382","DOI":"10.34067\/KID.0006722021","article-title":"Hepatorenal syndrome type 1: From diagnosis ascertainment to goal-oriented pharmacologic therapy","volume":"3","author":"Velez","year":"2021","journal-title":"Kidney360"},{"key":"B20-20241015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","article-title":"Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis","volume":"16","author":"Velez","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B21-20241015","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22-20241015","doi-asserted-by":"crossref","first-page":"627","DOI":"10.34067\/KID.0005692021","article-title":"Concomitant identification of muddy brown granular casts and low fractional excretion of urinary sodium in AKI","volume":"3","author":"Varghese","year":"2022","journal-title":"Kidney360"},{"key":"B23-20241015","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"},{"key":"B24-20241015","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa2022166","article-title":"A randomized trial of albumin infusions in hospitalized patients with cirrhosis","volume":"384","author":"China","year":"2021","journal-title":"N Engl J Med"},{"key":"B25-20241015","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1159\/000501299","article-title":"Point-of-care echocardiography unveils misclassification of acute kidney injury as hepatorenal syndrome","volume":"50","author":"Velez","year":"2019","journal-title":"Am J Nephrol"},{"key":"B26-20241015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/ajg.2017.122","article-title":"Acute kidney injury in cirrhosis: Baseline serum creatinine predicts patient outcomes","volume":"112","author":"Wong","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B27-20241015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"key":"B28-20241015","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1136\/gutjnl-2016-312670","article-title":"Acute-on-chronic liver failure: An update","volume":"66","author":"Hernaez","year":"2017","journal-title":"Gut"},{"key":"B29-20241015","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"B30-20241015","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1053\/j.ajkd.2011.07.017","article-title":"Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: A pooled analysis of clinical trials","volume":"58","author":"Velez","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"B31-20241015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000441151","article-title":"Hepatorenal acute kidney injury and the importance of raising mean arterial pressure","volume":"131","author":"Velez","year":"2015","journal-title":"Nephron"},{"key":"B32-20241015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJMe2034425","article-title":"Terlipressin and intravenous albumin in advanced cirrhosis\u2014Friend and foe","volume":"384","author":"Garcia-Tsao","year":"2021","journal-title":"N Engl J Med"},{"key":"B33-20241015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1365-2796.1999.00556.x","article-title":"Low-dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end-stage heart failure","volume":"246","author":"Eisenman","year":"1999","journal-title":"J Intern Med"},{"key":"B34-20241015","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00003246-199402000-00032","article-title":"Low-dose ornipressin improves renal function in the hepatorenal syndrome","volume":"22","author":"Evrard","year":"1994","journal-title":"Crit Care Med"},{"key":"B35-20241015","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/hep.510290629","article-title":"Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide","volume":"29","author":"Angeli","year":"1999","journal-title":"Hepatology"},{"key":"B36-20241015","doi-asserted-by":"crossref","first-page":"675948","DOI":"10.3389\/fphar.2021.675948","article-title":"Norepinephrine is more effective than midodrine\/octreotide in patients with hepatorenal syndrome-acute kidney injury: A randomized controlled trial","volume":"12","author":"El-Desoki Mahmoud","year":"2021","journal-title":"Front Pharmacol"},{"key":"B37-20241015","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"B38-20241015","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1681\/ASN.2021030336","article-title":"Impaired tubular secretion of organic solutes in advanced chronic kidney disease","volume":"32","author":"Mair","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B39-20241015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/ajcp\/aqx030","article-title":"Bile cast nephropathy in cirrhotic patients: Effects of chronic hyperbilirubinemia","volume":"147","author":"Foshat","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"B40-20241015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/ki.2013.78","article-title":"Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction","volume":"84","author":"van Slambrouck","year":"2013","journal-title":"Kidney Int"},{"key":"B41-20241015","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/liv.13394","article-title":"Bile acids and cardiovascular function in cirrhosis","volume":"37","author":"Voiosu","year":"2017","journal-title":"Liver Int"},{"key":"B42-20241015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5414\/CN109673","article-title":"Utility of a urine sediment score in hyperbilirubinemia\/hyperbilirubinuria","volume":"92","author":"Poloni","year":"2019","journal-title":"Clin Nephrol"},{"key":"B43-20241015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.23283","article-title":"Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome","volume":"51","author":"Nazar","year":"2010","journal-title":"Hepatology"},{"key":"B44-20241015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000487149","article-title":"Vancomycin-associated acute kidney injury with a steep rise in serum creatinine","volume":"139","author":"Velez","year":"2018","journal-title":"Nephron"},{"key":"B45-20241015","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1681\/ASN.2016080867","article-title":"Vancomycin-associated cast nephropathy","volume":"28","author":"Luque","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B46-20241015","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4103\/0971-4065.200522","article-title":"Acute ciprofloxacin-induced crystal nephropathy with granulomatous interstitial nephritis","volume":"27","author":"Goli","year":"2017","journal-title":"Indian J Nephrol"},{"key":"B47-20241015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s40800-018-0073-4","article-title":"Nephrotoxicity of ciprofloxacin: Five cases and a review of the literature","volume":"5","author":"Hajji","year":"2018","journal-title":"Drug Saf Case Rep"},{"key":"B48-20241015","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/j.gastro.2022.03.052","article-title":"The association between proton pump inhibitor exposure and key liver-related outcomes in patients with cirrhosis: A Veterans Affairs cohort study","volume":"163","author":"Mahmud","year":"2022","journal-title":"Gastroenterology"},{"key":"B49-20241015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0272-6386(87)80053-7","article-title":"Cirrhotic glomerulonephritis: Incidence, morphology, clinical features, and pathogenesis","volume":"9","author":"Newell","year":"1987","journal-title":"Am J Kidney Dis"},{"key":"B50-20241015","first-page":"585","article-title":"Hepatic uptake of circulating IgG immune complexes","volume":"55","author":"Skogh","year":"1985","journal-title":"Immunology"},{"key":"B51-20241015","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1093\/ndt\/14.10.2279","article-title":"Glomerular IgA deposition in liver disease","volume":"14","author":"Pouria","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"B52-20241015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/BF00430547","article-title":"Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part","volume":"392","author":"Nakamoto","year":"1981","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"B53-20241015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.kint.2021.03.033","article-title":"A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy","volume":"100","author":"Wheeler","year":"2021","journal-title":"Kidney Int"},{"key":"B54-20241015","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2215\/CJN.09180816","article-title":"Viral-associated GN: Hepatitis B and other viral infections","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"B55-20241015","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/hep.28297","article-title":"Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents","volume":"63","author":"Sise","year":"2016","journal-title":"Hepatology"},{"key":"B56-20241015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/nep.12795","article-title":"Clinical and morphologic spectrum of renal involvement in patients with HBV-associated cryoglobulinaemia","volume":"22","author":"Li","year":"2017","journal-title":"Nephrology (Carlton)"},{"key":"B57-20241015","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"key":"B58-20241015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.ackd.2016.03.002","article-title":"Intra-abdominal hypertension and abdominal compartment syndrome: An underappreciated cause of acute kidney injury","volume":"23","author":"Patel","year":"2016","journal-title":"Adv Chronic Kidney Dis"},{"key":"B59-20241015","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nrgastro.2013.210","article-title":"Cirrhotic cardiomyopathy: Pathogenesis and clinical relevance","volume":"11","author":"Wiese","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B60-20241015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492791","article-title":"Hepatorenal syndrome or hepatocardiorenal syndrome: Revisiting basic concepts in view of emerging data","volume":"9","author":"Kazory","year":"2019","journal-title":"Cardiorenal Med"},{"key":"B61-20241015","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1007\/BF02849965","article-title":"Midodrine: Insidious development of urologic adverse effects in patients with spinal cord injury: A report of 2 cases","volume":"24","author":"Vaidyanathan","year":"2007","journal-title":"Adv Ther"},{"key":"B62-20241015","doi-asserted-by":"crossref","first-page":"406","DOI":"10.34067\/KID.0006952020","article-title":"Patients with hepatorenal syndrome should be dialyzed? PRO","volume":"2","author":"Velez","year":"2020","journal-title":"Kidney360"},{"key":"B63-20241015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cld.2022.01.003","article-title":"Kidney replacement therapy in patients with acute liver failure and end-stage cirrhosis awaiting liver transplantation","volume":"26","author":"Kovvuru","year":"2022","journal-title":"Clin Liver Dis"},{"key":"B64-20241015","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J Hepatol"},{"key":"B65-20241015","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.26980","article-title":"Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury","volume":"60","author":"Belcher","year":"2014","journal-title":"Hepatology"},{"key":"B66-20241015","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1053\/j.ajkd.2020.03.016","article-title":"Clinical application of kidney biomarkers in cirrhosis","volume":"76","author":"Allegretti","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"B67-20241015","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1007\/s10620-012-2180-x","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis","volume":"57","author":"Verna","year":"2012","journal-title":"Dig Dis Sci"},{"key":"B68-20241015","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1111\/hepr.12917","article-title":"Serum adrenomedullin and urinary thromboxane B2 help early categorizing of acute kidney injury in decompensated cirrhotic patients: A prospective cohort study","volume":"48","author":"Liu","year":"2018","journal-title":"Hepatol Res"},{"key":"B69-20241015","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1515\/cclm-2017-0483","article-title":"Circulating miR-21, miR-210 and miR-146a as potential biomarkers to differentiate acute tubular necrosis from hepatorenal syndrome in patients with liver cirrhosis: A pilot study","volume":"56","author":"Watany","year":"2018","journal-title":"Clin Chem Lab Med"},{"key":"B70-20241015","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/1354750X.2019.1652347","article-title":"Urinary cell cycle arrest biomarker [TIMP-2]\u00b7[IGFBP7] in patients with hepatorenal syndrome","volume":"24","author":"Zhang","year":"2019","journal-title":"Biomarkers"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.03040322","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:07Z","timestamp":1786369507000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.03040322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":70,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03040322","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}